Match tier Listed
Presence Formerly Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-10-07

Yusra B. Medik

Role not yet determined Is this you? Add your title

Also affiliated: University of North Carolina at Chapel Hill (2018–2024); The University of Texas MD Anderson Cancer Center (2020–2024); University of Arkansas Medical Center (2025); Community Medical Center (2022–2024); Carolina Institute for NanoMedicine (2018–2021); Rutgers Health (2023); UNC Lineberger Comprehensive Cancer Center (2018–2021); Istanbul University (2020)

Formerly Arkansas Hematology Oncology Fellow, UAMS through 2027.

9 h-index 28 pubs 1,435 cited

  • Animals
  • Mice
  • Nanoparticles
  • Humans
  • Immunotherapy
  • Drug Delivery Systems
  • Interferon Type I
  • Mice, Inbred C57BL
  • Lung Neoplasms
  • Gastrointestinal Microbiome
  • Dietary Fiber
  • Female
  • Melanoma, Experimental
  • Probiotics
  • Dendritic Cells

Biography and Research Information

OverviewAI-generated summary

Yusra B. Medik's research program investigates the application of nanotechnology for improved cancer treatment and immunotherapy. Her work has explored nanoparticle-based co-delivery systems for chemotherapy agents, such as wortmannin and cisplatin, to enhance efficacy and overcome resistance in ovarian and non-small cell lung cancer models. Medik also studies the influence of the gut microbiome and dietary components, like fiber and probiotics, on the effectiveness of melanoma immunotherapy. Her research has further examined the role of immune cells, including CD103+ conventional dendritic cells, in vaccine efficacy against cancer. Additionally, her publications address the potential of nanotechnology to mitigate drug-induced hepatotoxicity and investigate immune-related toxicities associated with immunotherapy.

Metrics

  • h-index: 9
  • Publications: 28
  • Citations: 1,435

Positions

  • Hematology Oncology Fellow 2024–2027
    University of Arkansas for Medical Sciences Hematology and Medical Oncology ORCID
  • Resident Physician 2021–2024
    RWJBarnabas Health Internal Medicine ORCID
  • Postdoctoral Fellow 2018–2021
    MD Anderson Cancer Center Immunology ORCID
  • Research Fellow 2017–2018
    University of North Carolina Lineberger Cancer Research Center Nanotechnology Excellence Center ORCID

Selected Publications

  • Neuroendocrine Differentiation in Mature Cystic Teratomas in Adults: A Case Report and Review of the Literature (2026)
    The Permanente Journal DOI OpenAlex
  • Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care (2025)
    Cancers 2 citations DOI OpenAlex
  • Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers. (2025)
    Journal of Clinical Oncology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

15 Collaborators 2 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics